Balchem Corp. (BCPC)
NASDAQ:BCPC
Want to see BCPC full AI Analyst Report?
BCPC Stock Chart & Stats
$177.66
$0.69(0.44%)
At close: 4:00 PM EST
$177.66
$0.69(0.44%)
Day’s Range― - ―
52-Week Range$139.17 - $183.90
Previous CloseN/A
Volume32.16K
Average Volume (3M)195.93K
Market Cap
$5.19B
Enterprise Value$5.28B
Total Cash (Recent Filing)$72.87M
Total Debt (Recent Filing)$169.00M
Price to Earnings (P/E)34.0
Beta0.49
Next Earnings
Jul 24, 2026EPS Estimate
1.31Next Dividend Ex-DateN/A
Dividend Yield0.61%
Share Statistics
EPS (TTM)4.90
Shares Outstanding32,129,837
10 Day Avg. Volume183,751
30 Day Avg. Volume195,931
Financial Highlights & Ratios
PEG Ratio1.54
Price to Book (P/B)3.98
Price to Sales (P/S)4.82
P/FCF Ratio28.89
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue4.99
Enterprise Value/Gross Profit13.77
Enterprise Value/Ebitda19.44
Forecast
1Y Price Target
$212.00Price Target Upside19.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)5.24
Revenue Forecast (FY)$1.10B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet / Low LeverageMaterial reduction in leverage and rising equity provide financial flexibility to fund capex, M&A, and working capital without stressing liquidity. Low net leverage (~0.3 reported) and healthy cash balances reduce refinancing risk and support durable investment in growth initiatives over 2–6 months.
Sustained Margin ExpansionConsistent gross and operating margin expansion reflects structural gains from higher‑margin product mix, manufacturing efficiencies and pricing power. Sustained margin improvement underpins durable earnings quality and frees cash for reinvestment, making profitability less sensitive to short swings.
Strong Cash Generation And FCFOperating cash flow consistently above net income and improving free cash flow conversion provide a durable source of internal funding. Reliable cash generation supports dividends, debt reduction and strategic investments, lowering reliance on external finance over the medium term.
Bears Say
Input-cost Inflation RiskPetrochemical-driven raw material inflation can be structural for segments tied to commodity inputs and may cause persistent margin pressure until passthrough to customers occurs. Repeated cost shocks could compress margins and force recurring price negotiations or product mix shifts over several quarters.
Historically Uneven Revenue GrowthA history of choppy top-line performance indicates revenue is sensitive to end-market demand cycles and mix shifts. Even with a recent rebound, inconsistent growth raises execution risk for sustaining investment-led expansion and makes forward planning for capacity and margins more uncertain over the medium term.
Rising Operating ExpensesHigher fixed operating costs tied to sales, hiring and professional services can limit operating leverage if revenue growth slows. If investments take longer to generate returns, elevated OPEX may erode margin gains and cash flow resilience over multiple quarters, increasing execution risk.
Balchem News
BCPC FAQ
What was Balchem Corp.’s price range in the past 12 months?
Balchem Corp. lowest stock price was $139.17 and its highest was $183.90 in the past 12 months.
What is Balchem Corp.’s market cap?
Balchem Corp.’s market cap is $5.19B.
When is Balchem Corp.’s upcoming earnings report date?
Balchem Corp.’s upcoming earnings report date is Jul 24, 2026 which is in 78 days.
How were Balchem Corp.’s earnings last quarter?
Balchem Corp. released its earnings results on Apr 30, 2026. The company reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.245 by $0.005.
Is Balchem Corp. overvalued?
According to Wall Street analysts Balchem Corp.’s price is currently Undervalued.
Does Balchem Corp. pay dividends?
Balchem Corp. pays a Annually dividend of $0.96 which represents an annual dividend yield of 0.61%. See more information on Balchem Corp. dividends here
What is Balchem Corp.’s EPS estimate?
Balchem Corp.’s EPS estimate is 1.31.
How many shares outstanding does Balchem Corp. have?
Balchem Corp. has 32,129,837 shares outstanding.
What happened to Balchem Corp.’s price movement after its last earnings report?
Balchem Corp. reported an EPS of $1.25 in its last earnings report, beating expectations of $1.245. Following the earnings report the stock price went down -6.756%.
Which hedge fund is a major shareholder of Balchem Corp.?
Currently, no hedge funds are holding shares in BCPC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Balchem Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$212.00 (19.33% Upside)
$212.00 (19.33% Upside)
Blogger Sentiment
Bullish
BCPC Sentiment 100%
Sector Average 75%
Sector Average 75%
Hedge Fund Trend
Increased
By 120.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 0.5%
Last 30 Days ▲ 0.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.68%
12-Months-Change
Fundamentals
Return on Equity
12.38%
Trailing 12-Months
Asset Growth
4.71%
Trailing 12-Months
Company Description
Balchem Corp.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
BCPC Company Deck
BCPC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented multiple record financial metrics (revenue, adjusted EBITDA, adjusted EPS, gross margin dollars) and showcased broad-based growth across all three segments, strong cash generation, improved margins, sustainability achievements, and promising branded-ingredient progress (notably Vidacholine). Headwinds include emerging petrochemical-driven inflation, higher operating expenses tied to growth investments, and geopolitical-related supply-chain/freight risk that could cause modest margin compression in the near term. Overall, the positive operational and financial momentum, coupled with manageable leverage and clear strategic initiatives, outweigh the noted risks.View all BCPC earnings summariesBCPC Stock 12 Month Forecast
Average Price Target
$212.00
▲(19.33% Upside)
Technical Analysis
Ownership Overview
0.67% Insiders
29.70% Mutual Funds
15.57% Other Institutional Investors
26.69% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---